TECTONIC THERAPEUTIC, INC. Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TECTONIC THERAPEUTIC, INC. stock issued during period, value, restricted stock award, gross for the quarter ending 2026-06-30 was $77.00K, a 352.94% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. stock issued during period, value, restricted stock award, gross for the quarter ending 2026-03-31 was $412.00K.
- TECTONIC THERAPEUTIC, INC. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-06-30 was $17.00K.
- TECTONIC THERAPEUTIC, INC. stock issued during period, value, restricted stock award, gross for the quarter ending 2019-09-30 was $0.00.
- TECTONIC THERAPEUTIC, INC. stock issued during period, value, restricted stock award, gross for fiscal 2025 was $17.00K, a 13.33% increase from fiscal 2024.
- TECTONIC THERAPEUTIC, INC. stock issued during period, value, restricted stock award, gross for fiscal 2024 was $15.00K.
- TECTONIC THERAPEUTIC, INC. stock issued during period, value, restricted stock award, gross for fiscal 2018 was $0.00.
- TECTONIC THERAPEUTIC, INC. stock issued during period, value, restricted stock award, gross for fiscal 2017 was $0.00.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2026-06-30 | $77.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $412.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $17.00K 10-K · filed 2026-02-26 | |
| 2025-06-30 | $17.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $15.00K 10-K · filed 2026-02-26 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-11-07 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-11-07 | |
| 2018-12-31 | $0.00 10-K · filed 2019-03-25 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-13 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |